PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v6i3.3984ArticleResearch Progress of Traditional Chinese and Western Medicine in Hyperthyroid Heart Diseasehttps://artdesignp.com/journal/PAR/6/3/10.26689/par.v6i3.3984LiShuyu,ZhaoMingjun2022632022-05-30In recent years, hyperthyroid heart disease has become a condition with high incidence rate and high mortality rate. This paper discusses the pathogenesis, treatment, and influencing factors of hyperthyroid heart disease from two different angles – traditional Chinese medicine and western medicine – in hope to provide a reference basis for the treatment of hyperthyroid heart disease.

Poutasse CM, Herbstman JB, Peterson ME, et al., 2019, Silicone Pet Tags Associate Tris(1,3-dichloro-2-isopropyl) Phosphate Exposures with Feline Hyperthyroidism. Environ Sci Technol, 10(9): 23-24.

Sano M, Homma T, Ishige T, et al., 2017, An Autopsy Case of Hyperthyroid Cardiomyopathy Manifesting Lethal Congestive Heart Failure. Pathology International, 67(2): 110-112.

Qiang Z, Jin B, Lu Q, et al., 2019, Regulation of MicroRNA-146 in Hyperthyroid Heart Disease. Chinese Journal of Clinical Anatomy, 37(03): 273-277. DOI: 10.13418/j.issn.1001-165x.2019.03.007

Feng Y, 2020, Efficacy of Detection of cTnI, CK, CK-MB and NT-pro BNP Levels in the Diagnosis of Hyperthyroidism Heart Disease. Medical Journal of Chinese People’s Health, 32(24): 110-112.

Dillmann W, 2010, Cardiac Hypertrophy and Thyroid Hormone Signaling. Heart Fail Rev, 15(2): 125-132.

Hao X, Liu J, Cui Y, 2020, Analysis of Risk Factors of Hyperthyroidism Complicated with Hyperthyroid Heart Disease. Electronic Journal of Practical Gynecologic Endocrinology, 7(18): 151-152. DOI: 10.16484/j.cnki.issn2095-8803.2020.18.098

Wang W, Cheng Q, 2017, Analysis of Risk Factors of Hyperthyroidism Complicated with Hyperthyroid Heart Disease. Modern Instruments & Medical Treatment, 23(05): 43-44, 47.

Biondi B, Bartalena L, Cooper DS, et al., 2015, The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J, 4(3): 149-163.

Klein I, Danzi S, 2016, Thyroid Disease and the Heart. Curr Probl Cardiol, 41(2): 65-92.

Xiang Q, 2020, Effect of (131)-Iodine in the Treatment of Hyperthyroidism Heart Disease. Journal of Clinical Rational Drug Use, 13(23): 43-45. DOI: 10.15887/j.cnki.13-1389/r.2020.23.019

Huang LK, 2017, Clinical Analysis and Efficacy of 131I Iodine in the Treatment of Hyperthyroidism Heart Disease. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 5(26): 143-144. DOI: 10.16282/j.cnki.cn11-9336/r.2017.26.114

Tan X, 2020, (131) I Combined with Propranolol in the Treatment of Hyperthyroid Heart Disease. Medical Diet and Health, 18(20): 73, 76.

Ren Y, Ma J, Liu P, et al., 2020, Analysis of Risk Factors Associated with Hyperthyroidism of Heart Disease. Ningxia Medical Journal, 42(05): 406-408. DOI: 10.13621/j.1001-5949.2020.05.0406

Zhou Y, Zhang Z, 2017, Etiology and Pathogenesis of Hyperthyroidism. Henan Traditional Chinese Medicine, 37(10): 1771-1773.

Zhao X, Jiang Z, Fan G, 2019, Clinical Study and Analysis of Hyperthyroidism Heart Disease. Clinical Journal of Chinese Medicine, 11(25): 53-55.

Xing Y, Li Z, Zhou Y, et al., 2020, Li Zhongnan’s Experience in Treating Hyperthyroid Heart Disease. Henan Traditional Chinese Medicine, 40(08): 1200-1203. DOI: 10.16367/j.issn.1003-5028.2020.08.0304

Zhong X, Wang Y, 2019, Observation on the Efficacy of Self-Made Jianpi Jieyu Prescription Assisted by Symptomatic Intervention of Western Medicine in the Treatment of Heart Disease Secondary to Hyperthyroidism. Journal of Emergency in Traditional Chinese Medicine, 28(11): 2032-2034.

Pan J, Zhang J, Li Y, et al., 2017, Clinical Study of Shugan Yiqi Yangying Decoction in the Treatment of Hyperthyroid Heart Disease. Journal of Emergency in Traditional Chinese Medicine, 26(07): 1278-1280.

Du G, 2017, Treatment of 41 Cases of Hyperthyroidism Heart Disease with Xiaoyao Powder. China’s Naturopathy, 25(07): 57-58. DOI: 10.19621/j.cnki.11-3555/r.2017.07.045

Wang Q, 2018, Clinical Efficacy and Safety of Traditional Chinese Patent Medicine for Hyperthyroid Heart Disease: Study Protocol for A Systematic Review and Meta-Analysis. Medicine (Baltimore), 97(45): e13076. DOI: 10.1097/MD.0000000000013076

Yu Q, Song Z, 2016, Saizhi Combined with Danzhi Xiaoyao Powder in the Treatment of Hyperthyroid Heart Disease. Nei Mongol Journal of Traditional Chinese Medicine, 35(16): 22. DOI: 10.16040/j.cnki.cn15-1101.2016.16.025

Zhang Z, 2016, Analysis of Curative Effect of Shengmaiyin Combined with Western Medicine in Treating Hyperthyroidism Heart Disease. Cardiovascular Disease Journal of integrated traditional Chinese and Western Medicine, 4(16): 193-194. DOI: 10.16282/j.cnki.cn11-9336/r.2016.16.140

Wang Z, Wang X, Yang Y, et al., 2018, Clinical Observation of Anshendingzhao Pill in the Treatment of 86 Cases of Hyperthyroidism Heart Disease. World Latest Medical Information Abstracts, 18(12): 89, 97. DOI: 10.19613/j.cnki.1671-3141.2018.12.060